New LabPatch could change how diabetes patients track glucose

NCT ID NCT03262415

Completed Diagnosis Sponsor: Joslin Diabetes Center Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new device called LabPatch, a small patch worn on the arm that measures blood sugar levels continuously. Researchers compared its accuracy to standard lab tests and two commercial glucose meters. The study involved 30 adults with type 1 or type 2 diabetes to see if the patch works well enough for everyday use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: LabPatch Continuous Glucose Monitor (device)
What this could lead to: If accurate, this device could offer a new way for people with diabetes to track their glucose levels continuously without frequent finger sticks.
What could go wrong: This is a small, early-stage study with only 30 participants. The device may not be as accurate as standard monitors, and more testing is needed before it can be used widely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 2 DIABETES MELLITUS TYPE1 DIABETES MELLITUS

Contacts and locations

Locations

Joslin Diabetes Center

Boston, Massachusetts, 02215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.